TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
7.06
+0.36 (5.37%)
At close: Dec 5, 2025, 4:00 PM EST
7.20
+0.14 (1.98%)
After-hours: Dec 5, 2025, 6:57 PM EST
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $352.75 million as of December 5, 2025. Its market cap has increased by 215.21% in one year.
Market Cap
352.75M
Enterprise Value
364.19M
1-Year Change
215.21%
Ranking
Category
Stock Price
$7.06
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has increased from $328.75M to $352.75M, an increase of 7.30%. That is a compound annual growth rate of 1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 334.76M | 119.13% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |